Turnstone Biologics Corp. (Nasdaq:TSBX)
Health Care/Life Sciences • Biotechnology
CIK 1764974
Company
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It is focused on developing new medicines to treat and cure patients with solid tumors. The company was founded in 2015 and is headquartered in La Jolla, CA.
Address
9310 Athena Circle
Suite 300
La Jolla, California 92037
9310 Athena Circle
Suite 300
La Jolla, California 92037
Employees
None
None
Stock Info
Close
$3.9700
$3.9700
Day Range
3.9200 - 4.1000
3.9200 - 4.1000
52 Week Range
1.6250 - 13.2000
1.6250 - 13.2000
Average volume
131.04K
131.04K
Short Interest
342.34K (02/15/24)
342.34K (02/15/24)
% of Float Shorted
2.38%
2.38%
Market Cap
$96.99M
$96.99M
Revenue
$73.3M
$73.3M
Net Income
-$30.83M
-$30.83M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman Jerel Davis PhD |
President, Chief Executive Officer & Director Sammy J Farah PhD, MBA |
Director & Chief Medical Officer Michael M Burgess MD, PhD |
Director Clarence Patrick Machado |
Director Santhosh Palani PhD, CFA |
Director Kanya Rajangam MD, PhD |
Director Rishi Gupta |
Director Robert J Gould PhD |
Director Stefan Mathias Larson PhD |
SEC filings
Date | Form | Event |
---|---|---|
14 Aug, 2024 | 10-Q | |
14 Aug, 2024 | 8-K | |
2 Jul, 2024 | 4 | |
2 Jul, 2024 | 4 | |
2 Jul, 2024 | 4 | |
2 Jul, 2024 | 4 | |
2 Jul, 2024 | 4 | |
5 Jun, 2024 | 8-K | |
31 May, 2024 | SC 13G/A | |
13 May, 2024 | 8-K | |
13 May, 2024 | 10-Q | |
13 May, 2024 | S-8 | |
29 Apr, 2024 | SC 13G/A | |
22 Apr, 2024 | ARS | |
22 Apr, 2024 | DEFA14A | |
22 Apr, 2024 | DEF 14A | |
16 Apr, 2024 | 3 | |
16 Apr, 2024 | 8-K | |
16 Apr, 2024 | 4 | |
22 Mar, 2024 | 10-K | |
21 Mar, 2024 | 8-K | |
18 Mar, 2024 | SC 13G | |
5 Mar, 2024 | 8-K | |
9 Feb, 2024 | SC 13G/A | |
11 Jan, 2024 | 4 | |
13 Nov, 2023 | 10-Q | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
1 Sep, 2023 | 10-Q | |
3 Aug, 2023 | SC 13D | |
27 Jul, 2023 | SC 13G | |
27 Jul, 2023 | 4 | |
27 Jul, 2023 | SC 13G | |
27 Jul, 2023 | 4 | |
27 Jul, 2023 | 4 | |
25 Jul, 2023 | S-8 | |
25 Jul, 2023 | 8-K | |
24 Jul, 2023 | 4 | |
24 Jul, 2023 | 424B4 | IPO completed |
24 Jul, 2023 | 4 | |
24 Jul, 2023 | SC 13D | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | CERT | |
20 Jul, 2023 | S-1MEF | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | EFFECT | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
18 Jul, 2023 | CORRESP | |
18 Jul, 2023 | CORRESP | |
17 Jul, 2023 | S-1/A | |
17 Jul, 2023 | 8-A12B | |
5 Jul, 2023 | CORRESP | |
26 Jun, 2023 | S-1/A | |
23 Jun, 2023 | CORRESP | |
22 Jun, 2023 | UPLOAD | |
21 Jun, 2023 | CORRESP | |
12 Jun, 2023 | CORRESP | |
12 Jun, 2023 | UPLOAD | |
12 Jun, 2023 | S-1 | |
15 May, 2023 | DRS | |
14 Jul, 2021 | D |
Last update:2024-03-06 12:22:46.347258
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.